BCL2L1 and neoplasm: Similarly, downregulation of Bcl-xL protein expression by AS ODNs in various tumor cell lines resulted in activation of apoptosis, as well as decreased cellular proliferation and increased sensitivity to cytotoxic chemotherapeutic agents [15,16].